Stock Scorecard



Stock Summary for BioNTech SE (BNTX) - $94.50 as of 5/13/2025 8:19:22 PM EST

Total Score

9 out of 30

Safety Score

47 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for BNTX

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for BNTX

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for BNTX

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for BNTX

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for BNTX (47 out of 100)

Stock Price Rating (Max of 10) 9
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 9
Book Value to Price (Max of 10) 1
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 8
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for BNTX

New FDA Leadership Could Raise The Bar For Drug Approvals 5/9/2025 5:26:00 PM
Arbutus Presents Clinical Trial Data from its Two HBV Assets, Imdusiran and AB-101, at the European Association for the Study of the Liver ( EASL ) Congress 2025 5/7/2025 6:01:00 AM
Why BioNTech Stock Got Trounced on Tuesday 5/6/2025 10:15:00 PM
BioNTech Appoints Novartis Executive As Finance Chief, Reaffirms 2025 Outlook Focusing on Oncology Expansion - BioNTech ( NASDAQ:BNTX ) 5/5/2025 7:49:00 PM
BioNTech Announces First Quarter 2025 Financial Results and Corporate Update 5/5/2025 10:45:00 AM
BioNTech Announces Appointment of Ramón Zapata to Management Board as Chief Financial Officer 5/5/2025 10:30:00 AM
Want Safe Dividend Income in 2025 and Beyond? Invest in the Following 3 Ultra-High-Yield Stocks. 5/1/2025 8:15:00 AM
Prediction: Pfizer's Loss May Be Viking Therapeutics' Gain 4/30/2025 7:15:00 AM
Pfizer Q1 Earnings Beat Estimates, Several Headwinds Hurt Sales 4/29/2025 3:34:00 PM
Trump-Era FDA Appointees Request New Trials For Novavax COVID Vaccine, Reportedly Delaying Approval Timeline - Moderna ( NASDAQ:MRNA ) , BioNTech ( NASDAQ:BNTX ) 4/29/2025 7:57:00 AM

Financial Details for BNTX

Company Overview

Ticker BNTX
Company Name BioNTech SE
Country USA
Description BioNTech SE, a biotechnology company, develops and markets immunotherapies for cancer and other infectious diseases. The company is headquartered in Mainz, Germany.
Sector Name LIFE SCIENCES
Industry Name BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Most Recent Quarter 3/31/2025
Next Earnings Date 5/16/2025

Stock Price History

Last Day Price 94.50
Price 4 Years Ago 252.01
Last Day Price Updated 5/13/2025 8:19:22 PM EST
Last Day Volume 772,049
Average Daily Volume 1,392,936
52-Week High 131.49
52-Week Low 76.53
Last Price to 52 Week Low 23.48%

Valuation Measures

Trailing PE N/A
Industry PE 69.96
Sector PE 49.22
5-Year Average PE -10.52
Free Cash Flow Ratio 2.23
Industry Free Cash Flow Ratio 18.91
Sector Free Cash Flow Ratio 31.82
Current Ratio Most Recent Quarter 10.18
Total Cash Per Share 42.37
Book Value Per Share Most Recent Quarter 78.73
Price to Book Ratio 1.10
Industry Price to Book Ratio 9.00
Sector Price to Book Ratio 30.58
Price to Sales Ratio Twelve Trailing Months 8.51
Industry Price to Sales Ratio Twelve Trailing Months 43.08
Sector Price to Sales Ratio Twelve Trailing Months 25.54
Analyst Buy Ratings 13
Analyst Strong Buy Ratings 3

Share Statistics

Total Shares Outstanding 240,393,000
Market Capitalization 22,717,138,500
Institutional Ownership N/A

Dividends

Ex-Dividend Date 6/2/2022
Previous Dividend Amount 0.0000
Current Dividend Amount 2.1322
Total Years Dividend Increasing 0
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 1
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY -43.20%
Annual Earnings Growth -171.51%
Reported EPS 12 Trailing Months -3.61
Reported EPS Past Year -1.82
Reported EPS Prior Year -2.81
Net Income Twelve Trailing Months -772,730,554
Net Income Past Year -665,300,000
Net Income Prior Year 930,300,000
Quarterly Revenue Growth YOY -2.60%
5-Year Revenue Growth 90.87%
Operating Margin Twelve Trailing Months -270.50%

Balance Sheet

Total Cash Most Recent Quarter 10,184,900,000
Total Cash Past Year 9,761,900,000
Total Cash Prior Year 11,663,700,000
Net Cash Position Most Recent Quarter 9,947,400,000
Net Cash Position Past Year 9,547,200,000
Long Term Debt Past Year 214,700,000
Long Term Debt Prior Year 191,000,000
Total Debt Most Recent Quarter 237,500,000
Equity to Debt Ratio Past Year 0.99
Equity to Debt Ratio Most Recent Quarter 0.99
Total Stockholder Equity Past Year 19,411,100,000
Total Stockholder Equity Prior Year 20,245,900,000
Total Stockholder Equity Most Recent Quarter 18,926,600,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -1,151,947,970
Free Cash Flow Per Share Twelve Trailing Months -4.79
Free Cash Flow Past Year -244,600,000
Free Cash Flow Prior Year 4,665,900,000

Options

Put/Call Ratio 0.73
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.83
MACD Signal 0.54
20-Day Bollinger Lower Band 84.99
20-Day Bollinger Middle Band 107.09
20-Day Bollinger Upper Band 129.19
Beta 1.36
RSI 42.02
50-Day SMA 103.55
150-Day SMA 114.86
200-Day SMA 142.37

System

Modified 5/13/2025 7:17:18 PM EST